Sanbin Wang
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
Papers in
- Oncology 18
- CAR-T cell therapy research 13
- Hematology 12
- Hematopoietic Stem Cell Transplantation 9
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- Lei Gao (14 shared papers)Xi Zhang (13 shared papers)Li Gao (10 shared papers)Yao Liu (11 shared papers)Peiyan Kong (8 shared papers)Cheng Zhang (7 shared papers)Yi Su (5 shared papers)Jishi Wang (4 shared papers)
- Journals
- Blood (5 papers)Frontiers in Immunology (2 papers)Journal of Translational Medicine (2 papers)Cancer Research (2 papers)Haematologica (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Sanbin Wang
28 papers receiving 305 citations
Sanbin Wang's Hit Papers
Peers
Comparison fields: 5 of 52
- Hematology 118
- Oncology 146
- Genetics 52
- Immunology 62
- Public Health, Environmental and Occupational Health 42
Countries citing papers authored by Sanbin Wang
This map shows the geographic impact of Sanbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanbin Wang more than expected).
Fields of papers citing papers by Sanbin Wang
This network shows the impact of papers produced by Sanbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanbin Wang. The network helps show where Sanbin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Sanbin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial Hit paper breakdown → | 2024 | 51 |
| 2 | 2019 | 45 | |
| 3 | 2015 | 43 | |
| 4 | 2023 | 25 | |
| 5 | 2014 | 19 | |
| 6 | 2018 | 18 | |
| 7 | 2019 | 14 | |
| 8 | 2013 | 12 | |
| 9 | 2019 | 11 | |
| 10 | 2020 | 10 | |
| 11 | 2012 | 9 | |
| 12 | 2023 | 8 | |
| 13 | 2020 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2025 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2017 | 3 | |
| 19 | 2024 | 3 | |
| 20 | [HLA haploidentical peripheral blood stem cells transplantation for β thalassemia major]. | 2011 | 3 |
About Sanbin Wang
Sanbin Wang is a scholar working on Oncology, Hematology, Immunology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 35 papers that have together received 310 indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Hematopoietic Stem Cell Transplantation (9 papers), Acute Lymphoblastic Leukemia research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Immune Cell Function and Interaction (3 papers), Acute Myeloid Leukemia Research (2 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). The work is most often cited by research in Hematology (118 citations), Oncology (146 citations), Genetics (52 citations), Immunology (62 citations) and Public Health, Environmental and Occupational Health (42 citations). Sanbin Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Lei Gao, Xi Zhang, Li Gao, Yao Liu, Peiyan Kong, Cheng Zhang, Yi Su, Jishi Wang, Tonghua Yang and Cheng Zhang. Their work appears in journals such as Blood, Frontiers in Immunology, Journal of Translational Medicine, Cancer Research and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.